search icon

    Market Snapshot

    • S&P Futures

      3,914.75

    • Dow Futures

      31,478

    • Nasdaq Futures

      12,132.75

    blog search icon

    Akero Therapeutics, Inc.

    (NASDAQ:AKRO)

    $10.72

    $-0.21

    -1.92%

    Akero Therapeutics, Inc. Chart

    AKRO Stock Price Today

    Akero Therapeutics, Inc. (AKRO) stock declined over -1.92% intraday to trade at $10.72 a share on NASDAQ. The stock opened with a loss of -6.94% at $11.06 and touched an intraday high of $11.325, falling -1.92% against the last close of $10.93. The stock went to a low of $10.66 during the session.

    Stock Snapshot

    $10.93

    Prev. Close

    320.21 Million

    Market Cap

    $10.66

    Day Low

    $11.06

    Open

    35.01 Million

    Number of Shares

    $11.325

    Day High

    -

    P/E ratio

    -3.20

    EPS (TTM)

    5.38

    Cash Flow per Share

    15.70

    Free Float in %

    5.70

    Book Value

    492,572

    Volume

    Akero Therapeutics, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-23$11.06$11.325$10.66$10.72492,600
    2022-06-22$11.52$11.98$10.85$10.93594,800
    2022-06-21$12.14$12.45$11.66$11.76659,900
    2022-06-17$10.19$12.98$10.19$12.162,497,900
    2022-06-16$9.41$10.81$9.1$10.371,553,300
    2022-06-15$8.09$8.52$7.93$8.5380,000
    2022-06-14$8.08$8.1$7.77$8.05207,700
    2022-06-13$8.25$8.34$7.52$8.06451,100
    2022-06-10$8.48$8.6$8.305$8.54351,300
    2022-06-09$9.15$9.3$8.55$8.55245,100

    Contact Details

    601 Gateway Boulevard
    Suite 350
    South San Francisco, CA 94080
    United States

    Webiste:AKRO

    650 487 6488

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

    Frequently Asked Questions

    icon

    What is the current Akero Therapeutics, Inc. (AKRO) stock price?

    Akero Therapeutics, Inc. (NASDAQ: AKRO) stock price is $10.72 as of the last check on Thursday, June 23. During the trading session, AKRO stock reached the peak price of $11.325 while $10.66 was the lowest point it dropped to.

    icon

    AKRO's industry and sector of operation?

    The NASDAQ listed AKRO is part of Biotechnology industry that operates in the broader Health Care sector. Akero Therapeutics, Inc. , a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health.

    icon

    Who are the executives of AKRO?

    Dr. Andrew Cheng M.D., Ph.D.
    Pres, CEO & Director
    Dr. Jonathan M. Young
    Co-Founder, Exec. VP, COO & Sec.
    Dr. Timothy Rolph
    Co-Founder & Chief Scientific Officer
    Mr. William R. White J.D.
    Exec. VP, CFO, Treasurer & Head of Corp. Devel.

    icon

    What is the AKRO stock price today?

    AKRO stock traded closed the last session at $10.72, which is $-0.21 or -1.92% lower than its previous close of $10.93. AKRO's current trading price is 42.55% lower than its 52-week high of $28.94 where as its distance from 52-week low of 7.52% is -62.96%.

    icon

    How many employees does AKRO have?

    Number of AKRO employees currently stands at -. AKRO operates from 601 Gateway Boulevard, Suite 350, South San Francisco, CA 94080, United States.

    icon

    Link for AKRO official website?

    Official Webiste of $AKRO is: https://www.akerotx.com

    icon

    How do I contact AKRO?

    AKRO could be contacted at AKRO operates from 601 Gateway Boulevard, Suite 350, South San Francisco, CA 94080, United States, or at phone #650 487 6488 and can also be accessed through its website.

    icon

    How many shares of AKRO are traded daily?

    AKRO stock volume for the day was 492,572 shares while in the previous session number of AKRO shares traded was 492,600 . The average number of AKRO shares traded daily for last 3 months was 335.91 Thousands.

    icon

    How much did AKRO change today?

    The percentage change in AKRO stock occurred in the recent session was -1.92% while the dollar amount for the price change in AKRO stock was $-0.21.

    icon

    What price range AKRO stock been trading in?

    In the recent session, the day high for AKRO stock was $11.325 while the low for AKRO stock touched on the day was $10.66.

    icon

    What is the market cap of AKRO currently?

    The market value of AKRO currently stands at 320.21 Million with its latest stock price at $10.72 and 35.01 Million of its shares outstanding.